BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8649851)

  • 1. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.
    Arber N; Sutter T; Miyake M; Kahn SM; Venkatraj VS; Sobrino A; Warburton D; Holt PR; Weinstein IB
    Oncogene; 1996 May; 12(9):1903-8. PubMed ID: 8649851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
    Li YJ; Song R; Korkola JE; Archer MC; Ben-David Y
    Oncogene; 2003 May; 22(22):3452-62. PubMed ID: 12776197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of cyclin D1 overexpression by activated ras.
    Filmus J; Robles AI; Shi W; Wong MJ; Colombo LL; Conti CJ
    Oncogene; 1994 Dec; 9(12):3627-33. PubMed ID: 7970723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
    Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
    Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
    Gjetting T; Lukas J; Bartek J; Strauss M
    Biol Chem Hoppe Seyler; 1995 Jul; 376(7):441-6. PubMed ID: 7576242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression analysis proposes alternative pathways for the mechanism by which celecoxib selectively inhibits the growth of transformed but not normal enterocytes.
    Sagiv E; Rozovski U; Kazanov D; Liberman E; Arber N
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6807-15. PubMed ID: 18006783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
    Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
    J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
    Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
    Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
    Han EK; Sgambato A; Jiang W; Zhang YJ; Santella RM; Doki Y; Cacace AM; Schieren I; Weinstein IB
    Oncogene; 1995 Mar; 10(5):953-61. PubMed ID: 7898937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
    Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of anchorage-independent cell growth, adhesion, and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase.
    Mitra SK; Swarup G
    Exp Cell Res; 2001 Oct; 270(1):32-44. PubMed ID: 11597125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
    Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
    Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 gene expression in human cervical neoplasia.
    Nichols GE; Williams ME; Gaffey MJ; Stoler MH
    Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
    Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
    J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
    Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK
    Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
    Schmitz MJ; Hendricks DT; Farley J; Taylor RR; Geradts J; Rose GS; Birrer MJ
    Gynecol Oncol; 2000 Jun; 77(3):439-45. PubMed ID: 10831356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
    Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.